Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense
Despite scant evidence that it works, the drug, Aduhelm, is predicted to generate billions of dollars in revenue, much of it from Medicare.
- Next story Using light to monitor cancer
- Previous story New heart metric may improve survival for heart-failure patients, study finds
Explore more
- 177 Pieces of Life Advice from Kevin Kelly, Founding Editor of Wired Magazine & The Whole Earth Review
Image by Christopher Michel, via Wikimedia Commons I am a big admirer... - Ancient Judeans ate non-kosher seafood, fish bones show
Ancient Judeans ate non-kosher fish at a time when it was thought... - Elizabeth Warren invites billionaire rival Leon Cooperman to testify on her wealth tax
Democratic Senator Elizabeth Warren wants Leon Cooperman to testify on her proposed... - An attempted robbery at a Wells Fargo has turned into a hostage situation in Minnesota
There is an active hostage situation stemming from an attempted bank robbery... - The best laptop you can buy just got a major price cut for Prime Day
It’s Prime Day, and you can snag a great deal on the... - Lost Lead Reminds Mavericks Fans of 2006 Collapse
Fifteen years ago, the Mavericks lost the N.B.A. finals after winning the... - At least 19 killed in massive Baghdad hospital fire
At least 19 people died in a hospital fire in Baghdad Saturday... - Updates: N.Y.C. Mayoral Debate Is Shaken by Last-Minute Lineup Change
Eric Adams, under fire over residency questions, decided to join four other... - COVID-19 vaccine responses to be studied in people with immune deficits
A study assessing how people with immune system deficiencies or dysregulations respond... - Arkansas state trooper sued for allegedly causing a pregnant woman’s car to flip during traffic stop
An Arkansas woman is suing a state trooper after she claims he...